ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Callisto Pharmaceuticals,

Callisto Pharmaceuticals, (KAL)

0.00
0.00
(0.00%)
Cerrado 05 Diciembre 3:00PM
0.00
0.00
( 0.00% )

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
-
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
-
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

KAL Últimas noticias

Callisto Pharmaceuticals, Inc. Receives Notice of Delisting From Amex - Subject to Appeal -

Callisto Pharmaceuticals, Inc. (AMEX: KAL), announced today that on April 7, 2008, it received notice from the American Stock Exchange indicating that AMEX intends to strike the...

Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer

NEW YORK, Sept. 20 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

American Stock Exchange Accepts Callisto Pharamceuticals' Plan of Compliance and Extension to Regain Compliance with Standards

NEW YORK, Aug. 29 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal disorders...

Hagens Berman Sobol Shapiro: Class Action Lawsuit Filed Against Korean Air Lines

Plaintiff claims suffered damages in Korean Air Lines price fixing conspiracy SEATTLE, Aug. 10 /PRNewswire/ -- Seattle-based law firm Hagens Berman Sobol Shapiro filed a class action lawsuit...

Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, Aug. 9 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and inflammatory diseases...

Callisto Reports on Second-Quarter 2007 Milestones

Company Cites Continuing Progress on Clinical and Preclinical Programs NEW YORK, Aug. 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug...

Callisto Pharmaceuticals Raises $11.2 Million in Series B Preferred Stock Financing

NEW YORK, Aug. 7 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company primarily focused on the development of new drugs to treat cancer and...

Callisto Pharmaceuticals Opens Additional Site for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

NEW YORK, June 25 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and other major health threats...

Callisto Pharmaceuticals, Inc. Receives Notice From AMEX

NEW YORK, June 22 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (AMEX:KAL), a biopharmaceutical company primarily focused on the development of new drugs to treat cancer and...

Callisto Pharmaceuticals Files Suit Against Former Executive Vice President for Breach of Employment Agreement, Fraud, Conversio

NEW YORK, June 8 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a biopharmaceutical company focused on the development of new drugs to treat cancer and...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
PHGEBiomX Inc
US$ 0.788
(24.72%)
1
CVUCPI Aerostructures Inc
US$ 4.30
(16.69%)
43
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 192.38
(15.20%)
521.55k
CIXCompX International Inc
US$ 31.00
(10.52%)
1
GNSGenius Group Limited
US$ 0.92
(8.88%)
590.6k
IBDYishares ibonds Dec 2033 Term Corporate ETF
US$ 20.01
(-22.31%)
1
MSTZT Rex 2X Inverse MSTR Daily Target ETF
US$ 0.7788
(-15.35%)
34.04M
LODEComstock Inc
US$ 0.43
(-13.22%)
71.51k
AMBOAmbow Education Holding Ltd
US$ 1.63
(-10.44%)
898
GENCGencor Industries Inc
US$ 20.01
(-9.82%)
1
MSTZT Rex 2X Inverse MSTR Daily Target ETF
US$ 0.7788
(-15.35%)
34.04M
ETHU2x Ether ETF
US$ 11.69
(2.81%)
2.26M
KULRKULR Technology Group Inc
US$ 1.24
(8.77%)
1.12M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 30.79
(-0.29%)
1.04M
GNSGenius Group Limited
US$ 0.92
(8.88%)
590.6k
Filterthenoise Filterthenoise 1 minuto hace
Sounds like the FUD have INQR all figured out 🤣
INQR
SilkRoad SilkRoad 1 minuto hace
You haven’t been right once today. Even a broken clock is smarter than that. lol
KBLB
Huggy Bear Huggy Bear 1 minuto hace
This is true. Hire a morally bankrupt promoter and phish for fresh marks.
BQST
RIGATONI RIGATONI 2 minutos hace
$5.86 boomage ~Rig
ddls ddls 2 minutos hace
BIEL's market makers employ too many pumpers some are bashers just added to keep this worthless board alive.

Isn't it amazing how 99.9% of investors ignore all this. Yes, BioElectronics is an old worn out failing 20 year old pink piece of crap.

Let's look at the current
BIEL
StayHumble StayHumble 2 minutos hace
💹Yes! $UBQU💹iO does $5M🎃inRevenue Annually+Growing💹 💹w/ Facilities already in place to help make it happen. Just watch what we do!

https://x.com/CorporateUbqu/status/1767983893544566905?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E17679
UBQU
Gnarlyman Gnarlyman 3 minutos hace
The spinout of AESO comes with a share distribution. For every share of NIXX a shareholder owns they will receive an undetermined number of  shares of AESO stock. It has been established these share will come from the conversion of the AESO preferred shares. How many no ones knows. The date of recor
AESO NIXX
Jack Torrance Jack Torrance 3 minutos hace
Great news this morning. This is the equivalent of Breakthrough Therapy Designation in the UK. Sound like MM120 will get approval there around the same time it does in the States.
MNMD
SilkRoad SilkRoad 4 minutos hace
Warwick created knitted material. What Warwick couldn’t do was do a small batch narrow warp weave which was required to make ballistic panels for the U.S. Army. KBLB was referred to another company that could do the small batch narrow warp weave work. Get your facts straight.
KBLB
Uncle Monkey Uncle Monkey 5 minutos hace
no closer to a completed deal then a year ago, imho
CBRF
RIGATONI RIGATONI 5 minutos hace
Nice piece of news here...

May get some nice flips on dips with the heavy volume. That $5.50 area is next

TARA $5.12


https://finance.yahoo.com/news/protara-announces-positive-results-ongoing-120000586.html
jimr1717 jimr1717 5 minutos hace
Any updates on the cost today for the Korean Hedge Funds to add to their massive 6 trillion short shares? Tia
IFUS
iamthe walrus iamthe walrus 5 minutos hace
Minh Le from 22 X Ventures https://22xventures.com/ has been a big player in the work that has been done with Core Optics and Coretecs share exchange agreement and many other entities created in Virginia i have found all connected to these companies plus ZaiCell Inc and others . To many to list . H
CRTG
Polymer Paul Polymer Paul 5 minutos hace
Good to listen to what he said last year too..... And the year before that ... Ferrari.. Candence of catalyst... ubiquitous....foundries dragging them along... Two deals imminent!!!!! When you take all that into account ... Then he can say what he likes in your post. Nobody cares because he's a prov
LWLG
Debunkinator Debunkinator 5 minutos hace
One would sure think so buddy.🚂
ASII
Uncle Monkey Uncle Monkey 5 minutos hace
sad that mgmt can't provide an update...

even though fake news mod claimed no updates and just PR from now on...
CBRF
NASDAQ2020 NASDAQ2020 6 minutos hace
Did you try :
hydrocodone acetaminophen
ELTP
Hosai Hosai 6 minutos hace
"Missling's explanation was unfortunately not very coherent."

I think mostly he answered well but with the answer for the delay in showing the efficacy seperation at first I thought he'd misunderstood the question as seemed to be answering a question explaining for higher dropouts how
AVXL
Uncle Monkey Uncle Monkey 7 minutos hace
shouldn't pps be going up?
CBRF
Uncle Monkey Uncle Monkey 7 minutos hace
I expect more fake news and vague references to moving dirt around by fake news pumpers
CBRF
navycmdr navycmdr 7 minutos hace
Fannie / Freddie viable Consent decree EXIT PLAN -

3rd Qtr earnings / per share ... FNMA = $3.33 .... FMCC = $4.769 ... Bring it !

https://investorshub.advfn.com/uimage/uploads/2024/11/14/gftfeExit_plan_Consent.JPG
FMCC
jimr1717 jimr1717 7 minutos hace
Yes those nasty Korean Hedge Funds are short 7.8 Trillion shares. This should hit $36,814 a share when they cover.
This is what power11 posted so it has to be true.

Shrimpfraud.
SHMP
Huggy Bear Huggy Bear 7 minutos hace
Good Morning. Anyone have any walnuts for hire?
CBDW
linkvest linkvest 8 minutos hace
Should be out of the TRIPs today.
ASII
mike_dotcom mike_dotcom 8 minutos hace
Well, no news this week and it looks like very little interest in the stock after the big fireside chat. I still remain hopeful that someday the stock will get back to where it was three years ago. Waiting for Godot.
AVXL

Su Consulta Reciente

Delayed Upgrade Clock